These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34448180)

  • 1. PPP2R5D-Related Neurodevelopmental Disorder or Developmental and Epileptic Encephalopathy?: A Novel Phenotypic Description and Review of Published Cases.
    Madaan P; Kaur A; Saini L; Paria P; Vyas S; Sharma AR; Sahu JK
    Neuropediatrics; 2022 Feb; 53(1):20-25. PubMed ID: 34448180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Missense Variant in the Gene
    Yan L; Shen R; Cao Z; Han C; Zhang Y; Liu Y; Yang X; Xie M; Li H
    Biomed Res Int; 2021; 2021():6661860. PubMed ID: 33628804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An in-frame deletion affecting the critical acid loop of PPP2R5D is associated with a neonatal lethal form of PPP2R5D-related neurodevelopmental disorder.
    Alhajaj G; Lacroix C; Trakadis Y; Garfinkle J; Srour M
    Am J Med Genet A; 2023 Sep; 191(9):2416-2421. PubMed ID: 37248744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A disorder-related variant (E420K) of a PP2A-regulatory subunit (PPP2R5D) causes constitutively active AKT-mTOR signaling and uncoordinated cell growth.
    Papke CM; Smolen KA; Swingle MR; Cressey L; Heng RA; Toporsian M; Deng L; Hagen J; Shen Y; Chung WK; Kettenbach AN; Honkanen RE
    J Biol Chem; 2021; 296():100313. PubMed ID: 33482199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPP2R5D-Related Intellectual Disability and Neurodevelopmental Delay: A Review of the Current Understanding of the Genetics and Biochemical Basis of the Disorder.
    Biswas D; Cary W; Nolta JA
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32074998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical, neuroimaging and molecular characteristics of
    Oyama N; Vaneynde P; Reynhout S; Pao EM; Timms A; Fan X; Foss K; Derua R; Janssens V; Chung W; Mirzaa GM
    J Med Genet; 2023 May; 60(5):511-522. PubMed ID: 36216457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of a modified version of the gross motor function measure in PPPR5D related neurodevelopmental disorder.
    Kanner CH; Uher D; Zreibe K; Beard G; Patterson M; Harris M; Doerger J; Calamia S; Chung WK; Montes J
    Orphanet J Rare Dis; 2024 Feb; 19(1):45. PubMed ID: 38326877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo missense variants in PPP2R5D are associated with intellectual disability, macrocephaly, hypotonia, and autism.
    Shang L; Henderson LB; Cho MT; Petrey DS; Fong CT; Haude KM; Shur N; Lundberg J; Hauser N; Carmichael J; Innis J; Schuette J; Wu YW; Asaikar S; Pearson M; Folk L; Retterer K; Monaghan KG; Chung WK
    Neurogenetics; 2016 Jan; 17(1):43-9. PubMed ID: 26576547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Characteristics and Genotype-Phenotype Correlation in Children with KMT2E Gene-Related Neurodevelopmental Disorders: Report of Two New Cases and Review of Published Literature.
    Sharawat IK; Panda PK; Dawman L
    Neuropediatrics; 2021 Apr; 52(2):98-104. PubMed ID: 33111303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biallelic mutations in SZT2 cause a discernible clinical entity with epilepsy, developmental delay, macrocephaly and a dysmorphic corpus callosum.
    Nakamura Y; Togawa Y; Okuno Y; Muramatsu H; Nakabayashi K; Kuroki Y; Ieda D; Hori I; Negishi Y; Togawa T; Hattori A; Kojima S; Saitoh S
    Brain Dev; 2018 Feb; 40(2):134-139. PubMed ID: 28893434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative proteomics and phosphoproteomics of PP2A-PPP2R5D variants reveal deregulation of RPS6 phosphorylation via converging signaling cascades.
    Smolen KA; Papke CM; Swingle MR; Musiyenko A; Li C; Salter EA; Camp AD; Honkanen RE; Kettenbach AN
    J Biol Chem; 2023 Sep; 299(9):105154. PubMed ID: 37572851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early-onset parkinsonism in PPP2R5D-related neurodevelopmental disorder.
    Hetzelt KLML; Kerling F; Kraus C; Rauch C; Thiel CT; Winterholler M; Reis A; Zweier C
    Eur J Med Genet; 2021 Jan; 64(1):104123. PubMed ID: 33338668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and molecular description of 19 patients with GATAD2B-Associated Neurodevelopmental Disorder (GAND).
    Vera G; Sorlin A; Delplancq G; Lecoquierre F; Brasseur-Daudruy M; Petit F; Smol T; Ziegler A; Bonneau D; Colin E; Mercier S; Cogné B; Bézieau S; Edery P; Lesca G; Chatron N; Sabatier I; Duban-Bedu B; Colson C; Piton A; Durand B; Capri Y; Perrin L; Wiesener A; Zweier C; Maroofian R; Carroll CJ; Galehdari H; Mazaheri N; Callewaert B; Giulianno F; Zaafrane-Khachnaoui K; Buchert-Lo R; Haack T; Magg J; Rieß A; Blandfort M; Waldmüller S; Horber V; Leonardi E; Polli R; Turolla L; Murgia A; Frebourg T; Lebre AS; Nicolas G; Saugier-Veber P; Guerrot AM
    Eur J Med Genet; 2020 Oct; 63(10):104004. PubMed ID: 32688057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel nonsense mutation in PPP2R5D is associated with neurodevelopmental disorders and shows incomplete penetrance in a Chinese pedigree.
    Liu R; Huang Y; Li C; Wang P; Wang Y; Zhang L
    Clin Neurol Neurosurg; 2022 Dec; 223():107524. PubMed ID: 36403339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De Novo Pathogenic Variants in CACNA1E Cause Developmental and Epileptic Encephalopathy with Contractures, Macrocephaly, and Dyskinesias.
    Helbig KL; Lauerer RJ; Bahr JC; Souza IA; Myers CT; Uysal B; Schwarz N; Gandini MA; Huang S; Keren B; Mignot C; Afenjar A; Billette de Villemeur T; Héron D; Nava C; Valence S; Buratti J; Fagerberg CR; Soerensen KP; Kibaek M; Kamsteeg EJ; Koolen DA; Gunning B; Schelhaas HJ; Kruer MC; Fox J; Bakhtiari S; Jarrar R; Padilla-Lopez S; Lindstrom K; Jin SC; Zeng X; Bilguvar K; Papavasileiou A; Xing Q; Zhu C; Boysen K; Vairo F; Lanpher BC; Klee EW; Tillema JM; Payne ET; Cousin MA; Kruisselbrink TM; Wick MJ; Baker J; Haan E; Smith N; Sadeghpour A; Davis EE; Katsanis N; ; Corbett MA; MacLennan AH; Gecz J; Biskup S; Goldmann E; Rodan LH; Kichula E; Segal E; Jackson KE; Asamoah A; Dimmock D; McCarrier J; Botto LD; Filloux F; Tvrdik T; Cascino GD; Klingerman S; Neumann C; Wang R; Jacobsen JC; Nolan MA; Snell RG; Lehnert K; Sadleir LG; Anderlid BM; Kvarnung M; Guerrini R; Friez MJ; Lyons MJ; Leonhard J; Kringlen G; Casas K; El Achkar CM; Smith LA; Rotenberg A; Poduri A; Sanchis-Juan A; Carss KJ; Rankin J; Zeman A; Raymond FL; Blyth M; Kerr B; Ruiz K; Urquhart J; Hughes I; Banka S; ; Hedrich UBS; Scheffer IE; Helbig I; Zamponi GW; Lerche H; Mefford HC
    Am J Hum Genet; 2018 Nov; 103(5):666-678. PubMed ID: 30343943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanding the genetic and phenotypic spectrum of CHD2-related disease: From early neurodevelopmental disorders to adult-onset epilepsy.
    De Maria B; Balestrini S; Mei D; Melani F; Pellacani S; Pisano T; Rosati A; Scaturro GM; Giordano L; Cantalupo G; Fontana E; Zammarchi C; Said E; Leuzzi V; Mastrangelo M; Galosi S; Parrini E; Guerrini R
    Am J Med Genet A; 2022 Feb; 188(2):522-533. PubMed ID: 34713950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The broad phenotypic spectrum of PPP2R1A-related neurodevelopmental disorders correlates with the degree of biochemical dysfunction.
    Lenaerts L; Reynhout S; Verbinnen I; Laumonnier F; Toutain A; Bonnet-Brilhault F; Hoorne Y; Joss S; Chassevent AK; Smith-Hicks C; Loeys B; Joset P; Steindl K; Rauch A; Mehta SG; Chung WK; Devriendt K; Holder SE; Jewett T; Baldwin LM; Wilson WG; Towner S; Srivastava S; Johnson HF; Daumer-Haas C; Baethmann M; Ruiz A; Gabau E; Jain V; Varghese V; Al-Beshri A; Fulton S; Wechsberg O; Orenstein N; Prescott K; Childs AM; Faivre L; Moutton S; Sullivan JA; Shashi V; Koudijs SM; Heijligers M; Kivuva E; McTague A; Male A; van Ierland Y; Plecko B; Maystadt I; Hamid R; Hannig VL; Houge G; Janssens V
    Genet Med; 2021 Feb; 23(2):352-362. PubMed ID: 33106617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features of PPP2 syndrome type R5D (Jordan's syndrome) to support standardization of care.
    Levine AD; Chung WK
    Cold Spring Harb Mol Case Stud; 2023 Jun; 9(3):. PubMed ID: 37339871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dystonia as a prominent presenting feature in developmental and epileptic encephalopathies: A case series.
    Dzinovic I; Škorvánek M; Necpál J; Boesch S; Švantnerová J; Wagner M; Havránková P; Pavelekova P; Haň V; Janzarik WG; Berweck S; Diebold I; Kuster A; Jech R; Winkelmann J; Zech M
    Parkinsonism Relat Disord; 2021 Sep; 90():73-78. PubMed ID: 34399161
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.